Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
30.60
-0.92 (-2.92%)
At close: Mar 27, 2024, 4:00 PM
29.99
-0.61 (-1.99%)
After-hours: Mar 27, 2024, 7:41 PM EDT

Dianthus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Revenue
2.836.42000000
Revenue Growth (YoY)
-55.96%-------
Gross Profit
2.836.42000000
Selling, General & Admin
18.166.7427.9328.0923.7618.627.833.49
Research & Development
32.8429.3846.7750.6259.2141.3427.95.78
Operating Expenses
5136.1274.6978.782.9759.9635.739.27
Operating Income
-48.17-29.71-74.69-78.7-82.97-59.96-35.73-9.27
Interest Expense / Income
00000000.16
Other Expense / Income
-4.62-1.23-3.56-3.77-6.2-2.45-0.24-
Pretax Income
-43.56-28.48-71.14-74.94-76.77-57.52-35.49-9.43
Net Income
-43.56-28.48-71.14-74.94-76.77-57.52-35.49-9.43
Preferred Dividends
000000.090.020.3
Net Income Common
-43.56-28.48-71.14-74.94-76.77-57.6-35.51-9.74
Shares Outstanding (Basic)
51332100
Shares Outstanding (Diluted)
51332100
Shares Change
489.48%-74.54%25.11%18.66%101.28%890.33%1142.85%-
EPS (Basic)
-8.45-32.57-20.64-27.36-33.12-50.08-305.92-1042.40
EPS (Diluted)
-8.45-32.57-20.64-27.36-33.12-50.08-305.92-1042.40
Free Cash Flow
-36.97-29.21-60.8-64.42-60.16-49.55-24.46-6.67
Free Cash Flow Per Share
-7.17-33.41-17.70-23.47-26.01-43.11-210.78-714.04
Gross Margin
100.00%100.00%------
Operating Margin
-1704.67%-462.91%------
Profit Margin
-1541.22%-443.76%------
Free Cash Flow Margin
-1308.24%-455.18%------
EBITDA
-43.2-28.33-69.12-72.96-74.93-56.64-35.12-9.26
EBITDA Margin
-1528.66%-441.47%------
Depreciation & Amortization
0.360.152.021.981.840.880.380.01
EBIT
-43.56-28.48-71.14-74.94-76.77-57.52-35.49-9.27
EBIT Margin
-1541.22%-443.76%------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).